Wehbe Pharma Consulting ApS: Financial statements 2025
CVR: 45370984
Source: annual report 2025, Danish Business Authority
31/01/2025 – 31/12/2025
Wehbe Pharma Consulting ApS (CVR 45370984) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 888,231 and a net result of DKK -19,214. Equity in the 2025 report amounted to DKK 20,786. The solvency ratio was 15.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 888,231
- Profit/Loss
- DKK -19,214
- Equity
- DKK 20,786
- Total Assets
- DKK 132,657
- Employees
- 1
Official annual report
How creditworthy is Wehbe Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of January 31, 2025, Mohammed Wehbe is registered as director of Wehbe Pharma Consulting ApS.
As of January 31, 2025, Wehbe Holding ApS is registered as an owner of Wehbe Pharma Consulting ApS with an ownership share of 100%.
Wehbe Pharma Consulting ApS was founded on January 31, 2025.
About Wehbe Pharma Consulting ApS
Wehbe Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2025. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mohammed Wehbe. The company is owned by Wehbe Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 888,231 and a net result of DKK -19,214. Equity in the 2025 report amounted to DKK 20,786.